Incyte Corp. (INCY)
127.99
+0.18
(+0.14%)
USD |
NASDAQ |
Aug 24, 16:00
127.99
0.00 (0.00%)
After-Hours: 20:00
Incyte Total Assets (Quarterly) : 7.873B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.873B |
| March 31, 2026 | 7.339B |
| December 31, 2025 | 6.971B |
| September 30, 2025 | 6.330B |
| June 30, 2025 | 5.821B |
| March 31, 2025 | 5.749B |
| December 31, 2024 | 5.482B |
| September 30, 2024 | 5.012B |
| June 30, 2024 | 4.662B |
| March 31, 2024 | 7.136B |
| December 31, 2023 | 6.822B |
| September 30, 2023 | 6.388B |
| June 30, 2023 | 6.208B |
| March 31, 2023 | 5.798B |
| December 31, 2022 | 5.884B |
| September 30, 2022 | 5.510B |
| June 30, 2022 | 5.319B |
| March 31, 2022 | 5.054B |
| December 31, 2021 | 4.974B |
| September 30, 2021 | 4.199B |
| June 30, 2021 | 3.905B |
| March 31, 2021 | 3.661B |
| December 31, 2020 | 3.584B |
| September 30, 2020 | 3.307B |
| June 30, 2020 | 3.212B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.752B |
| December 31, 2019 | 3.427B |
| September 30, 2019 | 3.215B |
| June 30, 2019 | 2.948B |
| March 31, 2019 | 2.754B |
| December 31, 2018 | 2.646B |
| September 30, 2018 | 2.520B |
| June 30, 2018 | 2.397B |
| March 31, 2018 | 2.306B |
| December 31, 2017 | 2.303B |
| September 30, 2017 | 2.374B |
| June 30, 2017 | 1.639B |
| March 31, 2017 | 1.607B |
| December 31, 2016 | 1.639B |
| September 30, 2016 | 1.544B |
| June 30, 2016 | 1.418B |
| March 31, 2016 | 1.104B |
| December 31, 2015 | 1.007B |
| September 30, 2015 | 931.93M |
| June 30, 2015 | 930.34M |
| March 31, 2015 | 862.62M |
| December 31, 2014 | 830.07M |
| September 30, 2014 | 785.26M |
| June 30, 2014 | 679.11M |
| March 31, 2014 | 666.83M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 1.045B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| BioMarin Pharmaceutical, Inc. | 11.72B |
| Eli Lilly & Co. | 142.28B |
| Biogen, Inc. | 32.09B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.528B |
| Shareholders Equity (Quarterly) | 6.344B |
| Debt to Equity Ratio | 0.006 |
| Current Ratio | 4.593 |
| Net Debt Paydown Yield | 0.00% |